1. Home
  2. APGE vs SBLK Comparison

APGE vs SBLK Comparison

Compare APGE & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SBLK
  • Stock Information
  • Founded
  • APGE 2022
  • SBLK 2006
  • Country
  • APGE United States
  • SBLK Greece
  • Employees
  • APGE N/A
  • SBLK N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SBLK Marine Transportation
  • Sector
  • APGE Health Care
  • SBLK Consumer Discretionary
  • Exchange
  • APGE Nasdaq
  • SBLK Nasdaq
  • Market Cap
  • APGE 2.1B
  • SBLK 1.9B
  • IPO Year
  • APGE 2023
  • SBLK N/A
  • Fundamental
  • Price
  • APGE $44.32
  • SBLK $17.96
  • Analyst Decision
  • APGE Strong Buy
  • SBLK Strong Buy
  • Analyst Count
  • APGE 4
  • SBLK 3
  • Target Price
  • APGE $97.50
  • SBLK $22.67
  • AVG Volume (30 Days)
  • APGE 913.3K
  • SBLK 2.0M
  • Earning Date
  • APGE 08-11-2025
  • SBLK 08-06-2025
  • Dividend Yield
  • APGE N/A
  • SBLK 1.11%
  • EPS Growth
  • APGE N/A
  • SBLK N/A
  • EPS
  • APGE N/A
  • SBLK 1.96
  • Revenue
  • APGE N/A
  • SBLK $1,236,718,000.00
  • Revenue This Year
  • APGE N/A
  • SBLK N/A
  • Revenue Next Year
  • APGE $743.14
  • SBLK $14.96
  • P/E Ratio
  • APGE N/A
  • SBLK $8.85
  • Revenue Growth
  • APGE N/A
  • SBLK 25.60
  • 52 Week Low
  • APGE $26.20
  • SBLK $12.06
  • 52 Week High
  • APGE $63.50
  • SBLK $25.25
  • Technical
  • Relative Strength Index (RSI)
  • APGE 61.88
  • SBLK 71.36
  • Support Level
  • APGE $42.88
  • SBLK $16.88
  • Resistance Level
  • APGE $44.61
  • SBLK $17.60
  • Average True Range (ATR)
  • APGE 2.37
  • SBLK 0.47
  • MACD
  • APGE 0.12
  • SBLK 0.05
  • Stochastic Oscillator
  • APGE 63.45
  • SBLK 88.58

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.

Share on Social Networks: